MED12 is frequently mutated in ovarian and other adnexal Leiomyomas

In the female genital tract, extra-uterine leiomyomas such as those that arise in the ovary and paraovarian/paratubal regions are rare. Currently, little is known about the background genetic changes in such adnexal leiomyomas. Recent studies have found that the MED12 mutation is common in uterine leiomyomas, which suggests that such mutations may play an oncogenic role in smooth muscle neoplasms in females. Herein, we examined a series of ovarian and other adnexal leiomyomas in terms of MED12 mutational status to investigate possible MED12 involvement in the pathogenesis of extra-uterine smooth muscle tumors.

Source: Human Pathology - June 23, 2018 Category: Pathology Authors: Zhuo Li, Daichi Maeda, Yukitsugu Kudo-Asabe, Daisuke Tamura, Hiroshi Nanjo, Akimasa Hayashi, Masako Ikemura, Masashi Fukayama, Akiteru Goto Tags: Original Contributions Source Type: research